Description

5-Carbamoylamino-6-O-(3-amino-3,4-dideoxy-β-D-xylo-hexopyranuronosyl)-3,7-anhydro-1,5-dideoxy-1-(1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-β-D-threo-D-allo-octofuranuronic acid is a complex nucleoside analog with significant potential in advanced pharmaceutical research. This compound is valued for its intricate carbohydrate-modified structure, which is critical for developing novel therapeutic agents. It is primarily sought by research institutions and pharmaceutical companies engaged in the synthesis of antiviral drugs, enzyme inhibitors, and other high-value bioactive molecules.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel nucleoside-based antiviral and anticancer agents.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies, particularly those involving glycosyltransferases or nucleoside-processing enzymes.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Antiviral Drug Development: Investigated for its potential activity against a range of viral targets due to its modified nucleoside structure.
• Glycobiology Studies: Employed in research exploring the role of complex carbohydrates and nucleoside conjugates in biological recognition processes.
• Pre-clinical Candidate Synthesis: Used in the development and scale-up of potential pre-clinical drug candidates requiring sophisticated nucleoside chemistry.

Basic Information

Item	Details
Product Name	5-Carbamoylamino-6-O-(3-amino-3,4-dideoxy-β-D-xylo-hexopyranuronosyl)-3,7-anhydro-1,5-dideoxy-1-(1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-β-D-threo-D-allo-octofuranuronic acid
CAS No.	57973-16-7
Molecular Formula	C₁₉H₂₅N₅O₁₂
Molecular Weight	539.43 g/mol
Synonyms	5-Carbamoylamino-6-O-(3-amino-3,4-dideoxy-β-D-xylo-hexopyranuronosyl)-3,7-anhydro-1,5-dideoxy-1-(1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-β-D-threo-D-allo-octofuranuronic acid; 5'-O-Carbamoyl-3'-amino-3',4'-dideoxyuridine derivative; Complex Nucleoside-Xylouronate Conjugate; 5-Carbamoyl-3'-amino-3',4'-dideoxyuridine glycoside; Uridine-5'-carboxamide, 3'-amino-3',4'-dideoxy-, 6-O-(3-amino-3,4-dideoxy-β-D-xylo-hexopyranuronosyl) derivative; CAS 57973-16-7
EINECS	Contact for details

Quality Control

Our 5-Carbamoylamino-6-O-(3-amino-3,4-dideoxy-β-D-xylo-hexopyranuronosyl)-3,7-anhydro-1,5-dideoxy-1-(1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-β-D-threo-D-allo-octofuranuronic acid is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the exacting standards required for pharmaceutical research. A Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	< 20 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.